Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new clas...

Related Keywords

Florida ,United States ,University Of Florida ,Boston ,Massachusetts ,University Of Central Florida ,Portugal ,Lisbon ,Lisboa ,Ali Nagy Mckenna Miller ,Mark Joinnides ,Michaelj Fox Foundation ,Vaxxinity Inc ,University Of Florida Center ,Nasdaq ,Translational Research In Neurodegenerative Disease ,Journal Of Lipid Research ,Exchange Commission On ,Recent Clinical Pipeline ,Syn Seed Amplification Assay ,Mayo Clinic ,Chief Scientific Officer ,Vaccines Summit ,Recent Corporate ,Central Florida ,Translational Research ,Neurodegenerative Disease ,Year End ,Private Securities Litigation Reform Act ,Annual Report ,Exchange Commission ,